Therefore, using fibrates in conjunction with statins may offer additional benefits in reducing cardiovascular disease risk, particularly for patients with elevated Lp(a) levels, by decreasing apo(a) expression and improving Lp(a) clearance [29]. Here, LPA is linked to cardiovascular disorder.